You are viewing: Italy Carrier Screening Market analysis
Part of: Carrier Screening Market (Global)

The Italy Carrier Screening Market was valued at $70.9 Million in 2023 and projected to reach to $154.2 Million by 2028, representing a compound annual growth rate of 16.8%. Italy's carrier screening market is positioned for sustained growth through 2028, supported by enhanced healthcare policies promoting genetic testing and increased public awareness of hereditary conditions.

Italy Carrier Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Carrier Screening Market Trends and Insights

  • This growth trajectory in Italy is driven by increasing awareness of genetic disorders, rising adoption of prenatal and preconception screening, and strengthening healthcare infrastructure across the country.
  • Italy's aging population and emphasis on preventive healthcare have positioned carrier screening as a critical component of reproductive medicine. The Italian market benefits from robust regulatory frameworks and growing investment in genetic testing technologies.
  • Italy's healthcare system has increasingly integrated carrier screening into standard prenatal care protocols, supporting market expansion through 2028.
  • Enhanced reimbursement policies and public health initiatives in Italy are expected to accelerate adoption rates among both healthcare providers and patients seeking comprehensive genetic risk assessment..

Key Market Statistics

  • CAGR (2023-2028) 16.8% CAGR
  • Market Size, 2023 ~USD 70.9 Million
  • Forecast, 2028 ~USD 154.2 Million
  • Country Italy

Italy Carrier Screening Market Overview

Market Valuation Growth :

Italy's carrier screening market reached $70.9 million in 2023 and is expected to grow to $154.2 million by 2028, representing a 16.8% CAGR, driven by increased genetic awareness and healthcare modernization.

Prenatal & Preconception Adoption :

Rising adoption of prenatal and preconception screening programs across Italian healthcare facilities is accelerating market expansion, with growing patient demand for early genetic risk assessment.

Healthcare Infrastructure Development :

Strengthening healthcare infrastructure and investment in genetic testing capabilities across Italian regions are enabling broader access to carrier screening services and improving diagnostic accuracy.

Aging Population Impact :

Italy's aging demographic profile is increasing focus on hereditary disease prevention and family planning considerations, driving demand for comprehensive carrier screening among reproductive-age populations.

Italy Carrier Screening Market Dynamics

  • The Italian healthcare system's modernization efforts and integration of advanced diagnostic technologies are expanding service accessibility across urban and regional centers.
  • Growing collaboration between genetic counselors, obstetricians, and primary care providers is strengthening the screening ecosystem.
  • Additionally, favorable reimbursement policies and European regulatory alignment are expected to facilitate market penetration.
  • The convergence of demographic trends, technological advancement, and healthcare investment creates a robust foundation for market expansion in Italy..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Italy's carrier screening market is projected to more than double from $70.9M (2023) to $154.2M (2028) at a 16.8% CAGR.
      • Italy's healthcare system integration of carrier screening into prenatal protocols is a primary growth catalyst.
      • Increasing genetic disorder awareness and preventive healthcare emphasis in Italy are driving market expansion.
      • Italy's regulatory environment and reimbursement improvements support sustained adoption through 2028.

      Carrier Screening Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment PULMONARY CONDITIONS (Medical Condition)
      Forecast Period 2023-2028
      Growth Rate CAGR of 19.7% from 2023 to 2028
      Largest Segment SERVICES (Product & Service)
      Market Size Base Year (Billions) ~USD 2.2 (2023)
      Revenue Forecast (Billions) ~USD 5.4 (2028)
      Segments Covered Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028

      Italy Carrier Screening Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Customized Panel Testing
      • Expanded Carrier Screening
      • Predesigned Panel Testing
      • Targeted Disease Carrier Screening

      By Medical Condition

      • Hematological Conditions
      • Neurological Conditions
      • Other Medical Conditions
      • Pulmonary Conditions

      By Technology

      • Dna Microarrays
      • Dna Sequencing
      • Other Technologies
      • Pcr

      By End User

      • Clinical Laboratories
      • Fertility Clinics
      • Hospitals And Medical Centers
      • Other End Users

      By Product & 2021-2028

      • Products
      • Services

      ITALY: CARRIER SCREENING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      CLINICAL LABORATORIES13.315.217.620.423.727.531.937.416.2
      FERTILITY CLINICS5.46.177.9910.311.813.714.5
      HOSPITALS AND MEDICAL CENTERS31.536.642.950.35969.481.696.917.7
      OTHER END USERS2.73.13.43.94.34.95.56.312.9
      TOTAL52.96170.982.596112130.8154.216.8

      Target Audience

      • Diagnostic Laboratory Operators : Italian genetic testing labs and diagnostic centers need market intelligence to expand carrier screening service portfolios, optimize pricing strategies, and capture growing demand in prenatal and preconception segments.
      • Healthcare Providers & Hospitals : Italian hospitals and obstetric clinics require data on market trends and patient demand to justify investments in genetic screening infrastructure and integrate services into reproductive health programs.
      • Medical Device & Biotech Companies : Manufacturers of genetic testing platforms and screening technologies need Italy-specific market insights to develop localized solutions, navigate regulatory pathways, and establish distribution networks.
      • Healthcare Investors & Consultants : Investment firms and management consultants evaluating opportunities in Italian healthcare diagnostics need comprehensive market data to assess growth potential and identify acquisition or partnership targets.
      • Insurance & Reimbursement Specialists : Italian health insurance providers and reimbursement analysts require market analysis to understand screening adoption rates, cost-effectiveness data, and coverage policy implications for carrier screening services.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for Italy's carrier screening market with verified 16.8% CAGR projections through 2028, enabling accurate financial forecasting and investment decision-making for Italian market entry.
      • Regional Competitive Intelligence : Understand Italy-specific market dynamics, competitive landscape, and key growth drivers to identify opportunities for differentiation and strategic positioning within the Italian healthcare sector.
      • Healthcare Policy & Reimbursement Insights : Access detailed analysis of Italian healthcare policies, reimbursement frameworks, and regulatory requirements affecting carrier screening adoption and market accessibility across regions.
      • Demographic & Clinical Trends : Leverage Italy-specific demographic data and clinical adoption patterns to tailor product development, marketing strategies, and service offerings to local patient and provider needs.
      • Strategic Partnership Opportunities : Identify key stakeholders, healthcare institutions, and distribution channels specific to Italy's market to establish partnerships and accelerate market penetration in this high-growth segment.

      Frequently asked questions

      What is the current size of Italy's carrier screening market?

      Italy's carrier screening market was valued at $70.9 million in 2023 and is expected to reach $154.2 million by 2028.

      What is the projected growth rate for carrier screening in Italy?

      Italy's carrier screening market is projected to grow at a compound annual growth rate (CAGR) of 16.8% from 2023 to 2028.

      What factors are driving growth in Italy's carrier screening market?

      Key drivers include increased awareness of genetic disorders, rising adoption of prenatal and preconception screening, improved healthcare infrastructure, enhanced reimbursement policies, and public health initiatives across Italy.

      How is Italy's healthcare system supporting carrier screening adoption?

      Italy's healthcare system has integrated carrier screening into standard prenatal care protocols and strengthened regulatory frameworks to support market expansion and provider adoption.

      What is the forecast market size for Italy's carrier screening market in 2028?

      Italy's carrier screening market is forecasted to reach $154.2 million by 2028, representing more than a doubling of the 2023 market value.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).

      The following is a breakdown of the primary respondents:

      Breakdown of Primary Participants:

      Carrier Screening Market  Size, and Share

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Carrier Screening Market  Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Carrier Screening Market  Size, and Share

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.

      Market Definition

      Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.

      Market Stakeholders

      • Carrier screening product manufacturers, vendors, and distributors
      • Carrier screening service companies
      • Hospitals and private physician clinics
      • Reference laboratories
      • Donor banks
      • Health insurance payers
      • Research & consulting firms
      • Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Clinical Laboratories
      • Distributors of Carrier Screening Products and services

      Report Objectives

      • To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)  
      • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
      • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
      • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
      • Geographic Analysis:  Further breakdown of the European Carrier Screening Market into specific countries.  

      Get the Full Carrier Screening Market Report

      Full forecast, segment splits, and company analysis for all Carrier Screening Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status